Foamix Pharmaceuticals Ltd.
Healthcare · Medicinal Chemicals & Botanical Products · L3 · SEC filings ↗ · Compare ⊕
Financials
SEC XBRL · annual| FY19 | FY18 | FY17 | FY16 | FY15 | |
|---|---|---|---|---|---|
| Revenue | $308,000 | $906,000 | $3.7M | $5.5M | $849,000 |
| Operating income | −$15.9M | −$25.7M | −$65.6M | −$29.6M | −$16.9M |
| Net income | −$95.2M | −$74.2M | −$65.7M | −$29.3M | −$16.5M |
| Total assets | $81.2M | $103.7M | $80.3M | $135.6M | — |
| Total liabilities | $63.6M | $11.5M | $11.7M | $5.7M | — |
| Equity | $17.6M | $92.2M | $68.6M | $130.0M | $100.8M |
| EPS (diluted) | — | — | — | — | — |
| Shares out. | 54.4M | 37.6M | 37.5M | 37.2M | 30.6M |
Reported figures from the company's SEC filings (XBRL). Blank where a line item isn't cleanly tagged — never estimated.
Key ratios
from filings · FY2019- Operating margin
- −5157.1%
- Net margin
- −30901.9%
- Return on equity
- −541.6%
- Return on assets
- −117.3%
- Return on capital (ROCE)
- −30.6%
- Liabilities / assets
- 78.3%
- Debt / equity
- 3.62×
- Book value / share
- $0.32
- Revenue growth (YoY)
- −66.0%
- Net income growth (YoY)
- —
Computed from the company's own SEC figures — no market price, so these are facts, not a valuation. Book value per share is reported equity ÷ shares; it is not the stock price.
Financial health
forensic scores · FY2019- Altman Z″ (distress)
- -9.69distress
- Accruals / assets
- −26.8%clean
- Piotroski F-Score
- 1/9weak
Altman Z″is a textbook bankruptcy-distress score from book values only (>2.6 safe · 1.1–2.6 grey · <1.1 distress). Accruals = (net income − operating cash flow) ÷ assets; persistently high accruals are an earnings-quality red flag. Beneish M-Scoreis an eight-ratio screen comparing this year with last (M > −1.78 = elevated manipulation-risk screen, not proof). Piotroski F-Scorecounts how many of nine fundamental-health checks pass (shown as passed / applicable; we use operating margin and total liabilities as documented proxies where the exact input isn't XBRL-tagged). Computed from SEC filings — descriptive factors, not advice or a forecast.
Quality score
EDS ScoreOur own multi-factor score from free SEC data — profitability, growth, financial strength, earnings quality, and event/ownership catalysts. No market price and no licensed model: each axis is the share of source-backed checks it passes. Descriptive factors, not advice or a forecast. What these scores mean →
Signs
● 1 severe● 5 warning● 1 good- Altman Z″ in the distress zone
- Operating losses (negative operating margin)
- Reported a net loss
- Revenue declined year-over-year
- High leverage (liabilities > 70% of assets)
- Negative operating cash flow
- Clean earnings (low accruals)
Derived from the company's own SEC figures (fundamentals, forensic scores, filing discipline) — descriptive factors, not advice or a forecast.
Insider transactions
SEC Form 4 · most recent| Insider | Date | Type | Shares | Price |
|---|---|---|---|---|
| Stern StanleyDirector | Mar 9, 2020 | D | 21,147 | — |
| Wiley Matthew T.Officer — Chief Commercial Officer | Mar 9, 2020 | D | 35,275 | — |
| Stuart IainOfficer — Chief Scientific Officer | Mar 9, 2020 | D | 12,333 | — |
| Schwartz AharonDirector | Mar 9, 2020 | D | 112,200 | — |
| Kazanchyan AnnaDirector | Mar 9, 2020 | D | 15,714 | — |
| Hirsch StanleyDirector | Mar 9, 2020 | D | 52,842 | — |
| Harsch MutyaOfficer — CLO and General Counsel | Mar 9, 2020 | D | 12,742 | — |
| Hadar IlanOfficer — CFO & Country Manager | Mar 9, 2020 | D | 14,077 | — |
| Domzalski DavidOfficer — CEO | Mar 9, 2020 | D | 90,902 | — |
| Bruno Anthony DDirector | Mar 9, 2020 | D | 62,647 | — |
Headline trade per Form 4 (officers, directors, 10%+ owners). Buy/sell read from the filing's structured data — blank where a field isn't cleanly tagged.
Material events
SEC Form 8-K · most recent- Results of operations · Regulation FD disclosureMar 12, 2020
- Entered a material agreement · Completed an acquisition or disposition · Delisting / listing-standard notice · Modified shareholder rights · Change in control · Director / officer change · Amended charter or bylaws · Other material eventMar 10, 2020
- Shareholder vote · Other material eventFeb 6, 2020
- Regulation FD disclosureJan 14, 2020
- Other material eventJan 9, 2020
- New financial obligationDec 18, 2019
- Other material eventDec 16, 2019
- Entered a material agreementDec 4, 2019
Events the company reported on Form 8-K, labelled by the SEC item code it filed under — its own classification, not our interpretation.
Recent SEC filings
All filings ↗- EFFECTMar 20, 2020
- 15-12BFORM 15-12BMar 19, 2020
- S-8 POSMar 18, 2020
- S-8 POSMar 18, 2020
- S-8 POSMar 18, 2020
- S-8 POSMar 18, 2020
- POS AMMar 18, 2020
- 4FORM 4 SUBMISSIONMar 18, 2020
- 10-KMar 12, 2020
- 8-KMar 12, 2020
- 4FORM 4 SUBMISSIONMar 11, 2020
- 4FORM 4 SUBMISSIONMar 11, 2020
- 4FORM 4 SUBMISSIONMar 11, 2020
- 4FORM 4 SUBMISSIONMar 11, 2020
- 4FORM 4 SUBMISSIONMar 11, 2020
Event-driven situations (1)
Spot an error in this record? Report it. Every correction is verified against the source filing before we change anything.